Skip to main content
ENDO 2026 Main banner

Francesco Celi, MD, MHSc

Professor of Medicine and Chair
UNIVERSITY OF CONNECTICUT
Farmington, CT, United States

Dr. Celi is the Professor of Medicine and James E.C. Walker Chair of the Department of Medicine at UConn Health 

 

Prior of Joining UConn Health, Dr. Celi was the William G. Blackard Professor of Medicine and Chair of the Division of Endocrinology Diabetes and Metabolism at Virginia Commonwealth University in Richmond.  

Prior to joining VCU Dr. Celi worked for ten years as Clinical Investigator at the National Institute of Diabetes, Digestive, and Kidney Diseases in Bethesda Maryland. 

Dr. Celi is a graduate of the University of Rome “La Sapienza”, and a diplomate of the Board of Internal Medicine, with subspecialty in Endocrinology, Diabetes and Metabolism. Dr. Celi has completed his clinical fellowship in Endocrinology, at the University of Maryland in Baltimore. He was awarded the Masters in Health Sciences by Duke University. 

Dr. Celi is a practicing endocrinologist, and his clinical interest is on thyroid disorders and management of diabetes. 

Dr. Celi conducts clinical and translational research and his scientific interest is focused on the physiology and pathophysiology of thyroid hormone action as it relates to energy metabolism. Another area of research is in the mechanisms of adipose tissue differentiation and on the role of hormonal signaling on promoting differentiation of adipose tissue depots in thermogenic fat, able to dissipate energy.  

Dr. Celi’s clinical interests are thyroid disease, with a specific focus on thyroid hormone replacement therapy, imaging, fine needle aspiration biopsy, and multidisciplinary management of thyroid cancer. 

During his tenure at VCU Dr. Celi has worked on innovative care delivery models for patients with diabetes including creating an inpatient diabetes management team, testing the use of continuous glucose monitoring for patents admitted with COVID-19, developing a protected discharge service with remote home monitoring, and instituting a pre-surgical diabetes optimization. 

Disclosure information not submitted.

Presentation(s):